Company Description
Mobile-health Network Solutions, an investment holding company, provides telehealth solutions primarily in Singapore.
The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices.
It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website.
The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children’s health services, geriatric care services, and minor surgical procedures.
In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers.
Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services.
The company was founded in 2009 and is headquartered in Singapore.
| Country | Singapore |
| Founded | 2016 |
| IPO Date | Apr 10, 2024 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 88 |
| CEO | Dr. Pui Pui Teoh |
Contact Details
Address: 2 Venture Drive, #07-06/07 Vision Exchange Singapore, 608526 Singapore | |
| Phone | 65 6222 5223 |
| Website | manadr.com |
Stock Details
| Ticker Symbol | MNDR |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001976695 |
| ISIN Number | KYG622641093 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Dr. Tung Yeng Siaw | Co-Chief Executive Officer and Director |
| Dr. Pui Pui Rachel Teoh | Co-Chief Executive Officer, Chief Operating Officer and Chairwoman of the Board |
| Chee Yong Peng | Chief Financial Officer |
| Siew Siew Chan | Chief Technology Officer |
| Dr. Seng Taat Siaw | Chief Medical Officer |
| Pei Bei Law | Chief Business Officer |
| Chien Howh Chin | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2024 | 20-F/A | Filing |
| Oct 23, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Sep 30, 2024 | 6-K | Report of foreign issuer |
| Sep 23, 2024 | 6-K | Report of foreign issuer |
| Sep 20, 2024 | 6-K | Report of foreign issuer |
| Sep 6, 2024 | 6-K | Report of foreign issuer |
| Aug 22, 2024 | 6-K | Report of foreign issuer |
| May 21, 2024 | 6-K/A | Filing |
| May 20, 2024 | 6-K | Report of foreign issuer |
| Apr 22, 2024 | 6-K | Report of foreign issuer |